Moleculin Biotech, Inc.
MBRX
$2.34
-$0.10-4.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.88M | 6.70M | 7.56M | 7.72M | 4.28M |
| Total Receivables | 7.00K | 6.00K | 5.00K | 6.00K | 20.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 523.00K | 809.00K | 1.10M | 293.00K | 565.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 278.00K | 367.00K | 411.00K | 1.33M | 331.00K |
| Total Current Assets | 9.69M | 7.89M | 9.08M | 9.34M | 5.19M |
|
|
|||||
| Total Current Assets | 9.69M | 7.89M | 9.08M | 9.34M | 5.19M |
| Net Property, Plant & Equipment | 392.00K | 420.00K | 469.00K | 525.00K | 583.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 900.00K | 900.00K | 900.00K | -- | -- |
| Total Assets | 22.13M | 20.35M | 21.59M | 21.01M | 16.93M |
|
|
|||||
| Total Accounts Payable | 3.51M | 2.12M | 3.72M | 2.71M | 2.03M |
| Total Accrued Expenses | 3.21M | 3.43M | 4.06M | 4.07M | 3.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 137.00K | 132.00K | 128.00K | 124.00K | 120.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 6.85M | 5.68M | 7.91M | 6.90M | 5.36M |
|
|
|||||
| Total Current Liabilities | 6.85M | 5.68M | 7.91M | 6.90M | 5.36M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 222.00K | 258.00K | 292.00K | 326.00K | 358.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 44.00K | 41.33M | 20.55M | 13.75M | -- |
| Total Liabilities | 7.12M | 47.27M | 28.76M | 20.97M | 5.72M |
|
|
|||||
| Common Stock & APIC | 221.00M | 194.68M | 160.32M | 159.88M | 183.69M |
| Retained Earnings | -206.00M | -221.56M | -167.44M | -159.80M | -172.44M |
| Treasury Stock & Other | 10.00K | -44.00K | -38.00K | -38.00K | -41.00K |
| Total Common Equity | 15.01M | -26.92M | -7.17M | 42.00K | 11.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 15.01M | -26.92M | -7.17M | 42.00K | 11.21M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 15.01M | -26.92M | -7.17M | 42.00K | 11.21M |
|
|
|||||